Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Appoints Renowned Medical Expert and Pharmaceutical Researcher Dr. Paul Tam to its Board of Directors

GlobeNewswire May 1, 2019

Former Johnson & Johnson Executive Joins MediPharm

Stockhouse Editorial April 29, 2019

MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer

GlobeNewswire April 29, 2019

MediPharm Labs Executing on International Cannabis Extracts Strategy -- CFN Media

Newsfile April 25, 2019

MediPharm Labs Announces OTC Ticker Symbol Change to “MEDIF”

GlobeNewswire April 9, 2019

MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee

GlobeNewswire April 8, 2019

MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million

GlobeNewswire April 3, 2019

MediPharm Labs Acquires Over 5,000 KG of Dried Cannabis for Private Label Cannabis Oil Production and Launches New White Label Solutions Platform

GlobeNewswire April 1, 2019

5 of the Largest Cannabis Extraction Companies

GlobeNewswire March 27, 2019

MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire March 27, 2019

MediPharm Labs Expands Legal Team Adding Cannabis Expertise and Announces Participation at Upcoming Conferences

GlobeNewswire March 26, 2019

OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

PR Newswire March 13, 2019

A-Labs Capital II Corp. Announces Closing of Initial Public Offering

GlobeNewswire March 13, 2019

MediPharm Labs to Present at the 31st Annual ROTH Conference

GlobeNewswire March 12, 2019

Emerging Leaders in the Marijuana Industry

GlobeNewswire February 25, 2019

MediPharm Labs Signs First International Private Label Sale Agreement With AusCann for Cannabis Oil Export to Australia

GlobeNewswire February 21, 2019

MediPharm Labs Announces Listing on Frankfurt Stock Exchange

GlobeNewswire February 19, 2019

MediPharm Highlighted by Cannabis Media Coverage

Stockhouse Editorial February 13, 2019

CBD Market Now Supercritical; SCO2 Extraction Use Booms with CBD Demand

GlobeNewswire February 13, 2019

The Top Cannabis Stocks to Consider in a Market Worth $16.9 Billion

Accesswire February 12, 2019